GD Q1 Earnings Call: Aerospace Growth and Tariff Uncertainty Shape Outlook
Aerospace and defense company General Dynamics (NYSE:GD) reported Q1 CY2025 results topping the market's revenue expectations , with sales up 13.9% year on year to $12.22 billion. Its non-GAAP profit of $3.66 per share was 5.3% above analysts' consensus estimates.
Is now the time to buy GD? Find out in our full research report (it's free).
Revenue: $12.22 billion vs analyst estimates of $12 billion (13.9% year-on-year growth, 1.8% beat)
Adjusted EPS: $3.66 vs analyst estimates of $3.48 (5.3% beat)
Adjusted EBITDA: $1.49 billion vs analyst estimates of $1.45 billion (12.2% margin, 2.7% beat)
Operating Margin: 10.4%, in line with the same quarter last year
Free Cash Flow was -$290 million compared to -$437 million in the same quarter last year
Backlog: $88.66 billion at quarter end, down 5.4% year on year
Market Capitalization: $71.21 billion
General Dynamics' Q1 results were primarily driven by increased aircraft deliveries and ongoing momentum in its defense businesses. CEO Phebe Novakovic highlighted the ramp-up in Gulfstream G700 deliveries and noted, "We saw improved margins on our G700 deliveries," pointing to the introduction of newer models as a significant factor. The Technologies segment also contributed with consistent order activity, while Combat and Marine Systems benefited from stable demand and productivity gains, though supply chain challenges persisted.
Looking forward, management discussed the potential impact of recently announced tariffs and evolving government procurement priorities, particularly in aerospace. Novakovic acknowledged uncertainty, stating, "We do not know the scope and breadth of the tariffs issue at the moment and will not for a while." The company expects improved cash flow in the coming quarters, but remains cautious about macroeconomic risks and ongoing discussions with government customers regarding cost savings and contract structures.
General Dynamics' first quarter performance reflected robust aircraft deliveries and stable demand across core defense segments, with management addressing both operational improvements and emerging uncertainties.
Gulfstream G700 Drives Aerospace: The significant year-on-year increase in Aerospace revenue was attributed to a 50% rise in aircraft deliveries, including the introduction of 13 G700 jets. Margins in this segment improved due to scale and the gradual resolution of supply chain issues, though management noted the delivery cadence will normalize through the year.
G800 Certification Completed: The recent certification of the G800 by U.S. and European aviation authorities positions the company for expanded deliveries and future demand stimulation. Management expects the G800's entry into service to support ongoing aerospace growth.
Technologies Segment Order Strength: Technologies reported a book-to-bill ratio above 1.0, supported by demand for advanced IT and mission systems solutions. Management noted ongoing customer conversations around cost savings and contract structures, particularly outcome-based contracts, which could shape future margins.
Defense Segment Steady, but Supply Chain a Challenge: Combat and Marine Systems continued to see strong demand, especially from European customers and the U.S. Navy. However, Novakovic acknowledged persistent supply chain delays and quality issues, as well as the need for ongoing workforce expansion and productivity gains in shipbuilding.
Tariff and Macroeconomic Uncertainty: Management raised concerns regarding the potential impact of new tariffs on both aerospace and defense businesses but stopped short of providing estimates, citing a lack of clarity on how these might affect demand and cost structures in coming quarters.
Management's outlook for the remainder of the year centers on sustained demand for new aircraft, ongoing defense contract execution, and sensitivity to global trade policy changes.
Tariff Impact on Aerospace: Uncertainty around the magnitude and duration of new tariffs could influence export demand for Gulfstream jets and input costs, with management monitoring the situation closely.
Government Procurement and Cost Pressures: Shifts in U.S. government procurement strategies, including efforts to drive cost savings and contract reforms, may alter margin profiles and award timing, especially in the Technologies segment.
Supply Chain and Workforce Stability: Continued improvement in supply chain reliability and workforce productivity, particularly in shipbuilding and defense production, are necessary to maintain growth and meet delivery targets.
Peter Arment (Baird): Asked about visibility into Technologies segment bookings amid administration-driven cost savings efforts. Management noted ongoing discussions but highlighted a strong order book for the quarter.
David Strauss (Barclays): Questioned the effect of recent tariff announcements on Gulfstream order activity. Novakovic responded that the pipeline remains strong, though customers are cautious about potential tariff impacts.
Ken Herbert (RBC Capital Markets): Requested commentary on Gulfstream delivery cadence for the remainder of the year. Management indicated deliveries should remain consistent with previous estimates, barring significant supply chain disruptions.
Gavin Parsons (UBS): Inquired about margin progression in Aerospace and the effect of G800 certification on future orders. Novakovic confirmed that G800 margins are expected to be higher and that certification is generating customer interest.
Andre Madrid (BTIG): Raised concerns about potential trade tensions impacting European defense sales. Management emphasized that European operations are locally integrated, with strong demand persisting in the region.
In the coming quarters, our analysts will monitor (1) the pace of Gulfstream G800 and G700 deliveries and their impact on Aerospace growth, (2) the resolution of supply chain and workforce challenges, particularly in shipbuilding, and (3) any quantifiable effects from the introduction of new tariffs on both demand and margin profiles. The company's ability to adapt to evolving government procurement models and manage contract risk will also be key factors shaping near-term results.
General Dynamics currently trades at a forward P/E ratio of 18.1×. Is the company at an inflection point that warrants a buy or sell? Find out in our free research report.
The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.
While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years.
Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Sterling Infrastructure (+1,096% five-year return). Find your next big winner with StockStory today.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Stablecoin Issuer Circle Surges 168% in NYSE Debut After IPO Tops Price Expectations
Shares of Circle Internet Group (NYSE:CRCL) jumped 168% on Thursday following its initial public offering, which raised nearly $1.1 billion for the stablecoin firm and its selling shareholders. The stock debuted at $69 on the New York Stock Exchange, well above its IPO price of $31, and at one point hit a high of $103.75. Circle Internet Group (NYSE:CRCL) set its IPO price late Wednesday, significantly above both the revised $27–$28 range earlier in the week and the initial $24–$26 estimate from last week, giving the company a valuation of around $6.8 billion before trading began. By the end of the day, trading volume hit approximately 46 million shares, well above the number of publicly available shares. CEO Jeremy Allaire made the following statement on CNBC's 'Money Movers' on Thursday: 'To realize our vision, we needed to forge relationships with governments, we needed to work with policymakers … because if you want this to work for mainstream, it's got to work in mainstream society and you need to have those rules of the road. We've been one of the most licensed, regulated, compliant, transparent companies in the entire history of this industry, and that's served us well.' Allaire co-founded Circle Internet Group (NYSE:CRCL) in 2013. Originally headquartered in Boston, the company began with a focus on consumer payment solutions, along with crypto wallet and exchange services. In 2015, it became the first company to secure the notoriously hard-to-get BitLicense from New York State. Earlier this year, Circle relocated its headquarters to New York. While we acknowledge the potential of CRCL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
HSBC Upgrades Dr. Reddy's Laboratories Limited (RDY) to Buy from Hold
On June 5, HSBC upgraded Dr. Reddy's Laboratories Limited (NYSE:RDY) from Buy to Hold, raising the price target to INR1,445 from INR1,235, citing an optimistic outlook for the company in terms of earnings potential and solid market standing. A worker at a biopharmaceutical facility packaging an active pharmaceutical ingredient. HSBC's updated estimates for FY2026 to FY2028 take into account the shifting market tide for semaglutide and gRevlimid. The analysts are waiting for semaglutide to be introduced in Canada, Brazil, and India at the beginning of FY2027, which is a greater leap from their prior hypothesis of a launch only in Canada by Q4 of FY2026. The analysts revised their FY2026 sales figures for Dr. Reddy's Laboratories Limited (NYSE:RDY)'s gRevlimid, noting the growing competition. The adjustment includes a 5.1% decrease in the EPS estimate for FY2026, while the EPS forecast for FY2027 and FY2028 grew by 12% to 13%. According to HSBC analysts, the expected surge in semaglutide sales will strengthen Dr. Reddy's earnings. HSBC assigned a new price target for RDY's American Depositary Receipts (ADR) as well, raising it from $14.44 to $16.90. Dr. Reddy's Laboratories Limited (NYSE:RDY) is a global pharma company based in Hyderabad, India, that makes both branded and generic medicines for a wide range of health conditions. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. While we acknowledge the potential of RDY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
UBS Upholds Buy Recommendation on Deckers Outdoor (DECK)
On June 5, UBS analysts maintained a Buy rating on Deckers Outdoor Corporation (NYSE:DECK) with a price target of $169. The analysts expect Decker's EPS to top market estimates over the coming year as sales projections increase for its Hoka brand. They also anticipate UGG to keep up its record as a major global casual footwear brand. A customer browsing a retail store, finding the perfect footwear for their casual outfits. The analysts were confident that Deckers Outdoor Corporation (NYSE:DECK) could deliver a low double-digit compound annual sales growth. They forecast that this growth could drive Deckers' forward PE ratio over 20x, compared to the present 16.7x. The $169 price target by UBS reflects a 60% upside for DECK. The stock has plummeted nearly 47% over the last six months, which signals a buying opportunity. After discussions with company management on June 4, the analysts were optimistic about Deckers Outdoor Corporation (NYSE:DECK)'s potential for growth. Despite the market showing caution with reference to the Hoka brand's capacity to sustain robust growth, UBS believes that DECK is perfectly tackling concerns about industry competition, evolving fashion trends, and dependence on Clifton and Bondi franchises. The analysts see double-digit revenue growth for Hoka in the next few years. Deckers Outdoor Corporation (NYSE:DECK) designs and markets premium footwear and apparel worldwide with brands like UGG and HOKA. The company was established in 1973 and is headquartered in Goleta, California. While we acknowledge the potential of DECK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 11 Stocks That Will Bounce Back According To Analysts and 11 Best Stocks Under $15 to Buy According to Hedge Funds. Disclosure: None. Sign in to access your portfolio